Model
Edge
Five Prime Therapeutics, Inc.
0001329049
Filing type
4
Filing date
Mar 1, 2021
Updated
Mar 2, 2021 ยท 5:00 AM
Copy reference
Filing
4
Statement of Changes in Beneficial Ownership